Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combining tuberculin skin test with follow-on interferon gamma release assay markedly improves screening of household contacts.

Thorax·2025
Same author

Ambient PM<sub>2.5</sub> exposure and tuberculosis reactivation: a cross-sectional study in an intermediate burden city.

Epidemiology and infection·2025
Same author

Assessment of the Psychometric Properties of the Mask Usability Scale: A Measure of the Perceived Usability of N95 Respirators Among Healthcare Students and Staff.

Journal of advanced nursing·2024
Same author

No increased risk of tuberculosis-related immune reconstitution inflammatory syndrome with integrase inhibitor-based antiretroviral therapy in people with HIV with profound immunosuppression.

HIV medicine·2024
Same author

Association of smoking cessation with airflow obstruction in workers with silicosis: A cohort study.

PloS one·2024
Same author

Use of spirometry to detect airflow obstruction.

Respirology (Carlton, Vic.)·2024
Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026
Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026
Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026
Same journal

Documenting hospice care.

Lancet (London, England)·2026
Same journal

After the wood chipper.

Lancet (London, England)·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
See all related articles

Related Experiment Video

Updated: May 22, 2026

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust
10:45

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust

Published on: January 6, 2023

Silicosis.

Chi Chiu Leung1, Ignatius Tak Sun Yu, Weihong Chen

  • 1Tuberculosis and Chest Service, Centre for Health Protection, Department of Health, Hong Kong, China. cc_leung@dh.gov.hk

Lancet (London, England)
|April 27, 2012
PubMed
Summary
This summary is machine-generated.

Silicosis, a fibrotic lung disease from silica dust inhalation, causes progressive lung function impairment. While no cure exists, management strategies improve quality of life and slow disease progression.

More Related Videos

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica
05:03

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica

Published on: October 28, 2022

Related Experiment Videos

Last Updated: May 22, 2026

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust
10:45

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust

Published on: January 6, 2023

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica
05:03

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica

Published on: October 28, 2022

Area of Science:

  • Occupational Health
  • Pulmonary Medicine
  • Toxicology

Background:

  • Silicosis is a severe fibrotic lung disease caused by inhaling crystalline silica.
  • Occupational exposure to silica dust is prevalent across numerous industries.
  • Silica inhalation triggers lung inflammation and fibrosis via inflammasome activation.

Purpose of the Study:

  • To summarize the pathogenesis, diagnosis, and management of silicosis.
  • To highlight the association of silica exposure with other serious lung conditions.
  • To emphasize the need for improved hazard recognition and control, particularly in developing nations.

Main Methods:

  • Review of existing literature on silicosis pathogenesis.
  • Analysis of diagnostic criteria, including occupational history and radiological findings.
  • Examination of current management strategies and associated risks.

Main Results:

  • Silica inhalation leads to lysosomal damage and NALP3 inflammasome activation, causing lung inflammation and fibrosis.
  • Lung function impairment progresses even after exposure cessation.
  • Diagnosis requires documented occupational exposure and characteristic radiological features, excluding other conditions.

Conclusions:

  • Silicosis necessitates comprehensive management to improve patient quality of life and slow disease progression.
  • Associated risks include mycobacterial diseases, airway obstruction, and lung cancer.
  • Enhanced global efforts are crucial for silica hazard control, especially in developing countries.